345 related articles for article (PubMed ID: 23498357)
41. Assessment of half-mask elastomeric respirator and powered air-purifying respirator reprocessing for an influenza pandemic.
Lawrence C; Harnish DA; Sandoval-Powers M; Mills D; Bergman M; Heimbuch BK
Am J Infect Control; 2017 Dec; 45(12):1324-1330. PubMed ID: 28844381
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of facemasks for pediatric populations against submicron-sized aerosols.
Guha S; Mejía-Alfaro A; Hariharan P; Myers MR
Am J Infect Control; 2015 Aug; 43(8):871-7. PubMed ID: 26022658
[TBL] [Abstract][Full Text] [Related]
43. Particulate face masks for protection against airborne pathogens - one size does not fit all: an observational study.
Winter S; Thomas JH; Stephens DP; Davis JS
Crit Care Resusc; 2010 Mar; 12(1):24-7. PubMed ID: 20196710
[TBL] [Abstract][Full Text] [Related]
44. Healthcare personnel exposure in an emergency department during influenza season.
Rule AM; Apau O; Ahrenholz SH; Brueck SE; Lindsley WG; de Perio MA; Noti JD; Shaffer RE; Rothman R; Grigorovitch A; Noorbakhsh B; Beezhold DH; Yorio PL; Perl TM; Fisher EM
PLoS One; 2018; 13(8):e0203223. PubMed ID: 30169507
[TBL] [Abstract][Full Text] [Related]
45. Exposure to influenza virus aerosols during routine patient care.
Bischoff WE; Swett K; Leng I; Peters TR
J Infect Dis; 2013 Apr; 207(7):1037-46. PubMed ID: 23372182
[TBL] [Abstract][Full Text] [Related]
46. A survey of Alberta physicians' use of and attitudes toward face masks and face shields in the operating room setting.
Davis PJ; Spady D; Forgie SE
Am J Infect Control; 2007 Sep; 35(7):455-9. PubMed ID: 17765557
[TBL] [Abstract][Full Text] [Related]
47. Pandemic influenza: implications for infection control in hospital.
Aziz AM
Br J Nurs; 2008 Sep 11-24; 17(16):1020, 1022-6. PubMed ID: 19062454
[TBL] [Abstract][Full Text] [Related]
48. Surgical masks vs N95 respirators for preventing influenza.
Bitar R
JAMA; 2010 Mar; 303(10):937; author reply 938-9. PubMed ID: 20215602
[No Abstract] [Full Text] [Related]
49. Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection.
Chen SC; Chio CP; Jou LJ; Liao CM
Indoor Air; 2009 Oct; 19(5):401-13. PubMed ID: 19659895
[TBL] [Abstract][Full Text] [Related]
50. In vivo protective performance of N95 respirator and surgical facemask.
Li Y; Wong T; Chung J; Guo YP; Hu JY; Guan YT; Yao L; Song QW; Newton E
Am J Ind Med; 2006 Dec; 49(12):1056-65. PubMed ID: 17096360
[TBL] [Abstract][Full Text] [Related]
51. Effect of two-step hygiene management on the prevention of nosocomial influenza in a season with high influenza activity.
Ambrosch A; Rockmann F
J Hosp Infect; 2016 Oct; 94(2):143-9. PubMed ID: 27515458
[TBL] [Abstract][Full Text] [Related]
52. Validation and application of models to predict facemask influenza contamination in healthcare settings.
Fisher EM; Noti JD; Lindsley WG; Blachere FM; Shaffer RE
Risk Anal; 2014 Aug; 34(8):1423-34. PubMed ID: 24593662
[TBL] [Abstract][Full Text] [Related]
53. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel.
Miss RN; 2009; 71(4):13-8. PubMed ID: 20066893
[No Abstract] [Full Text] [Related]
54. A novel anti-influenza copper oxide containing respiratory face mask.
Borkow G; Zhou SS; Page T; Gabbay J
PLoS One; 2010 Jun; 5(6):e11295. PubMed ID: 20592763
[TBL] [Abstract][Full Text] [Related]
55. Using evidence-based medicine to protect healthcare workers from pandemic influenza: Is it possible?
Gralton J; McLaws ML
Crit Care Med; 2011 Jan; 39(1):170-8. PubMed ID: 21037474
[TBL] [Abstract][Full Text] [Related]
56. Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness.
MacIntyre CR; Zhang Y; Chughtai AA; Seale H; Zhang D; Chu Y; Zhang H; Rahman B; Wang Q
BMJ Open; 2016 Dec; 6(12):e012330. PubMed ID: 28039289
[TBL] [Abstract][Full Text] [Related]
57. Personal protective equipment in an influenza pandemic: a UK simulation exercise.
Phin NF; Rylands AJ; Allan J; Edwards C; Enstone JE; Nguyen-Van-Tam JS
J Hosp Infect; 2009 Jan; 71(1):15-21. PubMed ID: 19013670
[TBL] [Abstract][Full Text] [Related]
58. High Level Bioaerosol Protection against Infective Aerosols: How Medical Face Masks Compare against Respirators.
Sterr CM; Dick A; Schellenberger L; Zirbes J; Nonnenmacher-Winter C; Günther F
Can J Infect Dis Med Microbiol; 2022; 2022():6978661. PubMed ID: 36317154
[TBL] [Abstract][Full Text] [Related]
59. Short Communication: Health Interventions in Volcanic Eruptions-Community Wearability Assessment of Respiratory Protection against Volcanic Ash from Mt Sinabung, Indonesia.
Galea KS; Covey J; Mutia Timur S; Horwell CJ; Nugroho F; Mueller W
Int J Environ Res Public Health; 2018 Oct; 15(11):. PubMed ID: 30366426
[TBL] [Abstract][Full Text] [Related]
60. Respiratory Protection Against Emerging Infectious Diseases: Face Masks, Respirators, and Tools for Choosing Between Them.
Brown CK
Health Secur; 2019; 17(2):133-139. PubMed ID: 30964345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
